A pacemaker may be useful for atrial fibrillation (AFib) involving a slow heart rate or other heart conduction disorders. However, doctors may recommend lifestyle changes to manage AFib before a ...

Please provide your email address to receive an email when new articles are posted on . Among patients who had transcatheter aortic valve replacement, there was no difference in survival or adverse CV ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Pacemakers are not designed or approved to provide ...

Defibrillators and pacemakers help the heart maintain a regular rhythm. Defibrillators deliver a shock if the heart goes into arrhythmia. Pacemakers use electrical impulses to keep the heart from ...

A pacemaker can help your heart maintain a consistent rhythm. The procedure to insert a pacemaker typically involves a doctor making an incision in the skin that creates a “pocket” where the pacemaker ...

A wireless or leadless (without wires) pacemaker was implanted in a select group of children with irregular heart rhythms during a 5-year period (2016-2021). Smaller catheters that allow easier ...

A pacemaker, which unconfirmed media reports say Nancy Guthrie has, does not contain GPS and cannot be used to track a person's location. A pacemaker will continue to function even if it stops syncing ...

Please provide your email address to receive an email when new articles are posted on . Wireless pacemakers may be a safe and effective short-term option for children requiring permanent pacing.

An analysis of the NOAH – AFNET 6 trial used large language models to extract AF burden from pacemaker data in patients with device-detected atrial fibrillation. This approach enables to evaluate the ...

Though a Northwestern-developed quarter-size dissolvable pacemaker worked well in pre-clinical animal studies, cardiac surgeons asked if it was possible to make the device smaller. To reduce the size ...

At 30 days, bleeding and pacemaker rates were lower than in TRISCEND II, but long-term outcomes are eagerly awaited.